This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
BIOmarker Based Diagnostic TOOLkit to Personalise Pharmacological Approaches in Congestive Heart Failure: the BIOTOOL-CHF Validation Trial | MicrobiomeTrials
← Back to trials NCT07635810
BIOmarker Based Diagnostic TOOLkit to Personalise Pharmacological Approaches in Congestive Heart Failure: the BIOTOOL-CHF Validation Trial Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-15Est. Completion: 2027-09-06
Enrollment target: 600 participantsLocations IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy Other microbiome trials you might be interested in Trauma Injury Depression Anxiety Anger Pain
Animal assisted therapy (AAT) with dogs has been shown to be beneficial for a wide range of patients with both acute and…
Boston, United States Est. completion Dec 2026
Heart Failure
CRT improves outcomes in heart failure patients, but class II candidates (i.e. patients presenting non-LBBB or narrow LB…
Multiple Locations Est. completion Dec 15, 2027
Recruiting
Heart Failure With Reduced Ejection Fraction (HFrEF)
The goal of this clinical trial is to measure the effectiveness of video monitoring associated with the transition of ca…
Uberlândia, Brazil Est. completion Jun 1, 2027